TAO Synergies (TAOX) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
TAO Synergies (TAOX) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.20 Bn | 198.21 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 181.83 Bn | 178.65 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.47 Bn | 124.61 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.56 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 61.59 Bn | 56.40 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 54.65 Bn | 49.51 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.42 Bn | 30.13 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 30.21 Bn | 30.21 Bn | 1.16 Mn | -0.40 |
| 10 | TAO Synergies | 30.56 Mn | 30.56 Mn | - | -1.83 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.83 |
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | -2.36 |
| Sep 30, 2025 | -1.56 |
| Jun 30, 2025 | -11.26 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | -4.58 |
| Sep 30, 2024 | -4.58 |
| Jun 30, 2024 | -1.18 |
| Mar 31, 2024 | -0.41 |
| Dec 31, 2023 | -0.11 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -1.39 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | 0.62 |
| Sep 30, 2022 | -0.43 |
| Jun 30, 2022 | -0.54 |
| Mar 31, 2022 | -0.47 |
| Dec 31, 2021 | -0.84 |
| Sep 30, 2021 | -0.47 |